53.18
-0.02
(-0.04%)
Delayed:
3:11PM GMT+2
ETR
data delayed by 15 mins -
Disclaimer
Currency in EUR
| Range | 52.76 - 53.63 |
| 52 week | 47.98 - 60.24 |
| Open | 53.18 |
| Vol / Avg. | 304,822.00/3,703.00 |
| Mkt cap | 16.32B |
| P/E | 17.75 |
| Div/yield | 0.75/1.41 |
| EPS | 3.00 |
| Shares | 306.90M |
| Beta | - |
| Inst. own | - |
Events
Jun 18, 2013
Fresenius Medical Care at Wells Fargo Health Care Conference
Jun 18, 2013
Fresenius Medical Care at Citi European Healthcare Conference
Jun 12, 2013
Fresenius Medical Care at Goldman Sachs Healthcare Conference
May 30, 2013
Fresenius Medical Care at 38th Annual dbAccess Health Care Conference
May 28, 2013
Fresenius Medical Care at Citi Swiss Healthcare Investor Day
|
|
Key stats and ratios
| Q4 (Dec '12) | 2012 | |
| Net profit margin | 7.84% | 9.39% |
| Operating margin | 14.71% | 15.73% |
| EBITD margin | - | 19.64% |
| Return on average assets | 5.44% | 6.45% |
| Return on average equity | 11.54% | 14.15% |
| Employees | 86,153 | - |
| Carbon Disclosure Rating | - | 55/100 |
Address
Else-Kroener-Strasse 1
BAD HOMBURG, 61352
Germany
+49-6172-6090 (Phone)
+49-6172-6092301 (Fax)
BAD HOMBURG, 61352
Germany
+49-6172-6090 (Phone)
+49-6172-6092301 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
Fresenius Medical Care AG & Co KGaA is a Germany-based holding and kidney dialysis company, operating in the fields of dialysis products and dialysis services. Its dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, the Company sells dialysis products to other dialysis service providers. The Company operates in two business segments: North America and International. The North America segment consists of Renal Therapy Group and Fresenius Medical Services. The International segment consists of Europe and Latin America and one Asia-Pacific unit. During the year ended December 31, 2010, the Company's subsidiary, U.S. Vascular Access Holdings, LLC, completed the acquisition of National Vascular Care Inc.; it acquired a total of 168 existing clinics, and acquired Gambro AB�s peritoneal dialysis (PD) business. The Company has a total of 1000 subsidiaries worldwide.
Officers and directors
| Gerd Krick | Chairman of the Supervisory Board | |
| Rice Powell | Chairman of the Management Board, Chief Executive Officer | |
| Dieter Schenk | Vice Chairman of the Supervisory Board | |
| Michael Brosnan | Chief Financial Officer, Member of the Management Board | |
| Oliver Maier | Senior Vice President of Investor Relations | |
| Rainer Runte | Chief Compliance Officer, General Counsel, Member of the Management Board | |
| Roberto Fuste | Member of the Management Board | |
| Emanuele Gatti | Member of the Management Board | |
| Ronald Kuerbitz | Member of the Management Board | |
| Kent Wanzek | Member of the Management Board, Global Products Manufacturing Operations |
